Phellinus igniarius

Ethnobotanical Studies

Studies

Extraction, Purification, Structural Characterization, and Antitumor Effects of Water-Soluble Intracellular Polysaccharide (IPSW-1) from Phellinus igniarius Mycelia.

Summary

Researchers isolated and studied a polysaccharide from a Chinese medicine fungus, finding it has antioxidant and antitumor properties by inhibiting cell proliferation and promoting apoptosis. This compound could be developed into a functional food.

Boateng ID, Guo YZ and Yang XM (2024).
J Agric Food Chem.
PubMed:
39205635

Multi-target anti-diabetic styrylpyrones from Phellinus igniarius: Inhibition of α-glucosidase, protein glycation, and oxidative stress.

Summary

Phellinus igniarius SY489 extract contains potent α-glucosidase inhibitors, including novel compounds, with potential as anti-diabetic drugs. Study suggests they interact with enzyme via mixed-type mechanism for promising drug development.

Yu G et al (2024).
Int J Biol Macromol.
PubMed:
39168223

Serum metabolome analysis reveals medicinal fungi Phellinus igniarius ameliorated type 2 diabetes mellitus indications in rats via modulation of amino acid and carbohydrate metabolism.

Summary

Medicinal fungus P. igniarius improves blood glucose, cholesterol, and triglyceride levels in rats, possibly by affecting metabolic pathways. Potential treatment for type 2 diabetes.

Xia J et al (2024).
Biomed Chromatogr.
PubMed:
39113379

The Specific and Total CO(2) Emission Activity of Wood-Decaying Fungi and Their Response to Increases in Temperature.

Mukhin VA, Diyarova DK and Zhuykova EV (2024).
J Fungi (Basel).
PubMed:
39057333

Initial report on the multiple biological and pharmacological properties of hispolon: Exploring stochastic mechanisms.

Review
Aanniz T et al (2024).
Biomed Pharmacother.
PubMed:
38991301

Aqueous extract of Phellinus igniarius ameliorates hyperuricemia and renal injury in adenine/potassium oxonate-treated mice.

Wang L et al (2024).
Biomed Pharmacother.
PubMed:
38879892

Phelligridimer A enhances the expression of mitofusin 2 and protects against cerebral ischemia/reperfusion injury.

Summary

PA, an active compound from Phellinus igniarius, protects against cerebral ischemic injury by restoring mitochondrial function and reducing ER stress in both in vitro and in vivo models. This suggests PA could be a novel therapeutic agent for ischemic stroke.

Li X et al (2024).
Chem Biol Interact.
PubMed:
38825057

In Vitro Bioactivities and Characterization of Mycelial Extracts from Different Strains of Phellinus igniarius (Agaricomycetes).

Dong Y et al (2024).
Int J Med Mushrooms.
PubMed:
38780423

Development of RP HPLC-PDA method for simultaneous quantitative analysis of Inoscavin A and Meshimakobnol A and application on some Phellinus mushroom species.

Le AN, Nguyen TN and Dong DTA (2024).
Food Sci Nutr.
PubMed:
38726414

Bidirectional Solid-State Fermentation of Highland Barley by Edible Fungi to Improve Its Functional Components, Antioxidant Activity and Texture Characteristics.

Zhou X et al (2024).
Plant Foods Hum Nutr.
PubMed:
38639852

Comparative Transcriptome Analysis of Candidate Genes Associated with Mycelia Growth from a He-Ne Laser with Pulsed Light Mutant of Phellinus igniarius (Agaricomycetes).

Summary

Study identified key genes associated with increased mycelial production in mutant Phellinus igniarius JQ9, potentially improving production of bioactive compounds. Important for understanding and optimizing fungal fermentation processes in biotechnology and medicine.

Dong Y et al (2024).
Int J Med Mushrooms.
PubMed:
38421697

Antioxidant activity of Phellinus igniarius fermentation mycelia contributions of different solvent extractions and their inhibitory effect on α-amylase.

Summary

The study compared the polysaccharide contents of four strains and found that QB72 had higher production and better antioxidant and antidiabetic activities. Hot water extracts of QB72 showed potential as α-amylase inhibitors in food and medication.

Dong Y et al (2023).
Heliyon.
PubMed:
38234922

Effect of the Combination of Clostridium butyricum and Mycelium of Phellinus igniarius on Intestinal Microbiota and Serum Metabolites in DSS-Induced Colitis.

Zhao R et al (2024).
Nutrients.
PubMed:
38201981

A dihydromyricetin-loaded phellinus igniarius polysaccharide/l-arginine modified chitosan-based hydrogel for promoting wound recovery in diabetic mice via JNK and TGF-β/Smad signaling pathway.

Summary

Researchers created a dihydromyricetin-loaded hydrogel called PCD, which has antioxidant and anti-inflammatory properties. PCD promotes wound healing, showing potential to treat diabetic wounds.

Yang J et al (2024).
Int J Biol Macromol.
PubMed:
38176509

Ultrasound Intensify the Flavonoid Production of the Willow Bracket Mushroom, Phellinus igniarius (Agaricomycetes), Fermentation Mycelia.

Summary

Ultrasound can enhance bio-compound production by altering cell morphology, structure, and organelles. Flavonoid content and production increased significantly under specific ultrasound conditions compared to untreated fermentation.

Dong Y et al (2023).
Int J Med Mushrooms.
PubMed:
37947064

Phellinus igniarius Polysaccharides Ameliorate Hyperglycemia by Modulating the Composition of the Gut Microbiota and Their Metabolites in Diabetic Mice.

Summary

Researchers found that polysaccharides improved hyperglycemia symptoms, restored gut microbiota balance, and altered metabolic pathways in mice with type 2 diabetes, suggesting potential benefits for diabetes management.

Ni Z et al (2023).
Molecules.
PubMed:
37894615

Phellinus igniarius polysaccharides induced mitochondrial apoptosis of hepatic carcinoma by enhancing reactive oxygen species-mediated AKT/p53 signalling pathways.

Jin X et al (2023).
Nat Prod Res.
PubMed:
37328932

Citric Acid Changes the Fingerprint of Flavonoids and Promotes Their Accumulation in Phellinus igniarius (L.) Quél.

Dong H et al (2022).
Life (Basel).
PubMed:
36676017

Development of an HiBiT-tagged reporter H3N2 influenza A virus and its utility as an antiviral screening platform.

Zhang C et al (2023).
J Med Virol.
PubMed:
36424458

Medicinal fungus Phellinus igniarius alleviates gout in vitro by modulating TLR4/NF-kB/NLRP3 signaling.

Zhou X et al (2022).
Front Pharmacol.
PubMed:
36339594

Receptor-ligand affinity-based screening and isolation of water-soluble 5-lipoxygenase inhibitors from Phellinus igniarius.

Liu R et al (2022).
J Chromatogr B Analyt Technol Biomed Life Sci.
PubMed:
35973282

Anti-Gout Effects of the Medicinal Fungus Phellinus igniarius in Hyperuricaemia and Acute Gouty Arthritis Rat Models.

Li H et al (2022).
Front Pharmacol.
PubMed:
35087407

Screening anti-gout compounds from Phellinus igniarius by ultrafiltration liquid chromatography mass spectrometry based on evaluation of an in vitro method combined with enzymatic reaction.

Wang J et al (2021).
J Sep Sci.
PubMed:
34021686

Laser Mutagenesis of Phellinus igniarius Protoplasts for the Selective Breeding of Strains with High Laccase Activity.

Zhu Z et al (2020).
Appl Biochem Biotechnol.
PubMed:
31399928

Comparing the functional components, SOD-like activities, antimutagenicity, and nutrient compositions of Phellinus igniarius and Phellinus linteus mushrooms.

Yang NC et al (2016).
J Food Drug Anal.
PubMed:
28911588

Structural characterization and immunomodulatory effects of polysaccharides from Phellinus linteus and Phellinus igniarius on the IL-6/IL-10 cytokine balance of the mouse macrophage cell lines (RAW 264.7).

Suabjakyong P et al (2015).
Food Funct.
PubMed:
26190688